This study shows the normal flow pattern in the descending thoracic aorta and its reversal in coarctation due to collateral flow. Thus, VENC-MR can measure collateral flow in coarctation and serves as a unique method for providing this important measurement of the severity of coarctation of the aorta.
Objective. An elevated acute-phase response is associated with increased radiologic damage in rheumatoid arthritis (RA), but development of damage in previously normal joints ("new joint involvement") has not previously been investigated. This study was undertaken to investigate the hypothesis that when there is suppression of disease activity as judged by the C-reactive protein level, new joint involvement is reduced to a greater extent than is progression in already damaged joints ("damaged joint progression").Methods. Three hundred fifty-nine patients with active RA were studied as part of a 5-year randomized, prospective, open-label study of disease-modifying antirheumatic drug therapy. Time-averaged CRP was calculated from samples obtained every 6 months, and patients were divided into groups with CRP values of < < <6, 6-< < <12, 12-< < <25, and > > >25 mg/liter. Radiographs of the hands and feet were scored by the Larsen method; a damaged joint was defined as one with a score of > > >2.Results. The rank correlation between timeintegrated CRP and increase in Larsen score was 0.50; the correlation increased to 0.59 for patients entering the study with disease duration of < < <2 years. The percentage of new joint involvement over 5 years varied markedly with time-integrated CRP, from 7.3% in the CRP < < <6 mg/liter group to 39.1% in the CRP > > >25 mg/liter group (5.4-fold increase). The percentage of damaged joint progression increased from 26.1% in the CRP < < <6 mg/liter group to 41.6% in the CRP > > >25 mg/liter group (1.6-fold increase).Conclusion. The results of this study provide further confirmation that high CRP levels over time are associated with greater radiologic progression. Although radiologic progression still occurred in both previously normal and damaged joints despite the presence of normal CRP levels, this consisted of proportionately less new joint involvement compared with damaged joint progression. These findings support the idea that disease-suppressive therapy should be instituted at an early stage in patients with RA, before erosive damage has occurred.
These findings suggest that velocity-encoded NMR imaging can be used to estimate regurgitant volume and regurgitant fraction in patients with mitral regurgitation and can discriminate patients with moderate or severe mitral regurgitation from normal subjects and patients with mild regurgitation. It may be useful for monitoring the effect of therapy intended to reduce the severity of mitral regurgitation.
The interstudy reproducibility of velocity-encoded cine (VEC) magnetic resonance (MR) imaging for quantification of regurgitant volume (RV) and regurgitant fraction (RF) was studied in 10 patients with chronic aortic regurgitation. Each patient underwent two VEC MR imaging studies. RV and RF were measured on the aortic flow curve by quantifying antegrade and retrograde flow per cardiac cycle. VEC MR imaging measurements for RV and RF correlated closely with volumetric measurements for both studies (r greater than .97). Interstudy reproducibility for VEC MR imaging measurement of RV and RF was high (r greater than .97), and the interstudy variability for VEC MR imaging measurements was low. These results demonstrate a high accuracy of VEC MR imaging for measurement of RV and RF in patients with chronic aortic regurgitation. The level of interstudy reproducibility of VEC MR imaging for quantitative assessment of RV and RF indicates the potential of this technique for follow-up and monitoring of response to therapy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.